nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—EIF4E—uterine cervix—uterine fibroid	0.0353	0.0511	CbGeAlD
Sirolimus—EIF4E—uterus—uterine fibroid	0.0294	0.0426	CbGeAlD
Sirolimus—FGF2—myometrium—uterine fibroid	0.0277	0.0401	CbGeAlD
Sirolimus—EIF4E—female reproductive system—uterine fibroid	0.0265	0.0383	CbGeAlD
Sirolimus—FGF2—uterine cervix—uterine fibroid	0.0215	0.0312	CbGeAlD
Sirolimus—FGF2—smooth muscle tissue—uterine fibroid	0.0209	0.0303	CbGeAlD
Sirolimus—FGF2—decidua—uterine fibroid	0.0205	0.0297	CbGeAlD
Sirolimus—FGF2—urethra—uterine fibroid	0.0198	0.0287	CbGeAlD
Sirolimus—FGF2—endometrium—uterine fibroid	0.0195	0.0282	CbGeAlD
Sirolimus—FGF2—mammalian vulva—uterine fibroid	0.0188	0.0273	CbGeAlD
Sirolimus—FKBP1A—nipple—uterine fibroid	0.0184	0.0267	CbGeAlD
Sirolimus—FGF2—uterus—uterine fibroid	0.018	0.026	CbGeAlD
Sirolimus—MTOR—myometrium—uterine fibroid	0.0176	0.0254	CbGeAlD
Sirolimus—SLC47A1—nipple—uterine fibroid	0.0158	0.0229	CbGeAlD
Sirolimus—FKBP1A—myometrium—uterine fibroid	0.0158	0.0229	CbGeAlD
Sirolimus—FGF2—female gonad—uterine fibroid	0.0147	0.0213	CbGeAlD
Sirolimus—FGF2—vagina—uterine fibroid	0.0146	0.0211	CbGeAlD
Sirolimus—EIF4E—Signaling mediated by p38-alpha and p38-beta—ESR1—uterine fibroid	0.014	0.0453	CbGpPWpGaD
Sirolimus—SLC47A1—myometrium—uterine fibroid	0.0136	0.0197	CbGeAlD
Sirolimus—MTOR—smooth muscle tissue—uterine fibroid	0.0133	0.0192	CbGeAlD
Sirolimus—MTOR—endometrium—uterine fibroid	0.0124	0.0179	CbGeAlD
Sirolimus—FKBP1A—uterine cervix—uterine fibroid	0.0123	0.0178	CbGeAlD
Sirolimus—MTOR—mammalian vulva—uterine fibroid	0.012	0.0173	CbGeAlD
Sirolimus—FKBP1A—smooth muscle tissue—uterine fibroid	0.0119	0.0173	CbGeAlD
Sirolimus—FKBP1A—decidua—uterine fibroid	0.0117	0.017	CbGeAlD
Sirolimus—MTOR—uterus—uterine fibroid	0.0114	0.0165	CbGeAlD
Sirolimus—FKBP1A—urethra—uterine fibroid	0.0113	0.0164	CbGeAlD
Sirolimus—FKBP1A—endometrium—uterine fibroid	0.0111	0.0161	CbGeAlD
Sirolimus—FKBP1A—mammalian vulva—uterine fibroid	0.0108	0.0156	CbGeAlD
Sirolimus—SLC47A1—uterine cervix—uterine fibroid	0.0106	0.0153	CbGeAlD
Sirolimus—FKBP1A—cardiac atrium—uterine fibroid	0.0103	0.0149	CbGeAlD
Sirolimus—FKBP1A—uterus—uterine fibroid	0.0102	0.0148	CbGeAlD
Sirolimus—MTOR—female reproductive system—uterine fibroid	0.0102	0.0148	CbGeAlD
Sirolimus—SLC47A1—decidua—uterine fibroid	0.0101	0.0146	CbGeAlD
Sirolimus—SLC47A1—urethra—uterine fibroid	0.00971	0.0141	CbGeAlD
Sirolimus—SLC47A1—endometrium—uterine fibroid	0.00956	0.0138	CbGeAlD
Sirolimus—MTOR—female gonad—uterine fibroid	0.00932	0.0135	CbGeAlD
Sirolimus—MTOR—vagina—uterine fibroid	0.00926	0.0134	CbGeAlD
Sirolimus—SLC47A1—mammalian vulva—uterine fibroid	0.00924	0.0134	CbGeAlD
Sirolimus—FKBP1A—female reproductive system—uterine fibroid	0.00921	0.0133	CbGeAlD
Sirolimus—SLC47A1—uterus—uterine fibroid	0.00881	0.0127	CbGeAlD
Sirolimus—FKBP1A—female gonad—uterine fibroid	0.00838	0.0121	CbGeAlD
Sirolimus—FKBP1A—vagina—uterine fibroid	0.00833	0.0121	CbGeAlD
Sirolimus—SLC47A1—female reproductive system—uterine fibroid	0.00792	0.0115	CbGeAlD
Sirolimus—SLCO1B1—female reproductive system—uterine fibroid	0.00781	0.0113	CbGeAlD
Sirolimus—EIF4E—Leptin signaling pathway—ESR1—uterine fibroid	0.00761	0.0246	CbGpPWpGaD
Sirolimus—SLC47A1—female gonad—uterine fibroid	0.0072	0.0104	CbGeAlD
Sirolimus—SLC47A1—vagina—uterine fibroid	0.00716	0.0104	CbGeAlD
Sirolimus—FGF2—PI-3K cascade—TNRC6B—uterine fibroid	0.00646	0.0209	CbGpPWpGaD
Sirolimus—FGF2—PI3K/AKT activation—TNRC6B—uterine fibroid	0.00631	0.0204	CbGpPWpGaD
Sirolimus—FGF2—GAB1 signalosome—TNRC6B—uterine fibroid	0.00626	0.0203	CbGpPWpGaD
Sirolimus—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.00612	0.0198	CbGpPWpGaD
Sirolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00561	0.0181	CbGpPWpGaD
Sirolimus—CYP3A7—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00553	0.0179	CbGpPWpGaD
Sirolimus—CYP3A5—uterine cervix—uterine fibroid	0.00535	0.00775	CbGeAlD
Sirolimus—MTOR—LKB1 signaling events—ESR1—uterine fibroid	0.0049	0.0159	CbGpPWpGaD
Sirolimus—FGF2—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00483	0.0156	CbGpPWpGaD
Sirolimus—MTOR—PI-3K cascade—TNRC6B—uterine fibroid	0.0048	0.0155	CbGpPWpGaD
Sirolimus—MTOR—PI3K/AKT activation—TNRC6B—uterine fibroid	0.00468	0.0151	CbGpPWpGaD
Sirolimus—MTOR—GAB1 signalosome—TNRC6B—uterine fibroid	0.00465	0.015	CbGpPWpGaD
Sirolimus—FGF2—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00462	0.015	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00455	0.0147	CbGpPWpGaD
Sirolimus—CYP3A7—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00455	0.0147	CbGpPWpGaD
Sirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.00454	0.0147	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB4—PGR—uterine fibroid	0.0045	0.0146	CbGpPWpGaD
Sirolimus—FGF2—Downstream signal transduction—TNRC6B—uterine fibroid	0.00435	0.0141	CbGpPWpGaD
Sirolimus—FGF2—Signaling by FGFR—TNRC6B—uterine fibroid	0.00432	0.014	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB2—TNRC6B—uterine fibroid	0.0043	0.0139	CbGpPWpGaD
Sirolimus—FGF2—DAP12 signaling—TNRC6B—uterine fibroid	0.00428	0.0139	CbGpPWpGaD
Sirolimus—FGF2—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00422	0.0137	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—HMGA2—uterine fibroid	0.0042	0.0136	CbGpPWpGaD
Sirolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00405	0.0131	CbGpPWpGaD
Sirolimus—FGF2—DAP12 interactions—TNRC6B—uterine fibroid	0.00403	0.013	CbGpPWpGaD
Sirolimus—FGF2—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00403	0.013	CbGpPWpGaD
Sirolimus—FGF2—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00403	0.013	CbGpPWpGaD
Sirolimus—CYP3A5—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.004	0.0129	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR—TNRC6B—uterine fibroid	0.00399	0.0129	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00396	0.0128	CbGpPWpGaD
Sirolimus—FGF2—Signaling by PDGF—TNRC6B—uterine fibroid	0.00394	0.0127	CbGpPWpGaD
Sirolimus—FGF2—B Cell Activation—TNRC6B—uterine fibroid	0.00373	0.0121	CbGpPWpGaD
Sirolimus—ABCB1—myometrium—uterine fibroid	0.00365	0.00529	CbGeAlD
Sirolimus—CYP3A5—female gonad—uterine fibroid	0.00365	0.00528	CbGeAlD
Sirolimus—CYP3A5—vagina—uterine fibroid	0.00363	0.00525	CbGeAlD
Sirolimus—MTOR—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00359	0.0116	CbGpPWpGaD
Sirolimus—FGF2—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00357	0.0115	CbGpPWpGaD
Sirolimus—MTOR—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00343	0.0111	CbGpPWpGaD
Sirolimus—MTOR—Regulation of Telomerase—ESR1—uterine fibroid	0.0034	0.011	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00338	0.0109	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—PGR—uterine fibroid	0.00334	0.0108	CbGpPWpGaD
Sirolimus—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00329	0.0106	CbGpPWpGaD
Sirolimus—MTOR—Downstream signal transduction—TNRC6B—uterine fibroid	0.00323	0.0104	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR—TNRC6B—uterine fibroid	0.00321	0.0104	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00319	0.0103	CbGpPWpGaD
Sirolimus—MTOR—DAP12 signaling—TNRC6B—uterine fibroid	0.00318	0.0103	CbGpPWpGaD
Sirolimus—MTOR—Leptin signaling pathway—ESR1—uterine fibroid	0.00314	0.0102	CbGpPWpGaD
Sirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00313	0.0101	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—HPSE2—uterine fibroid	0.0031	0.01	CbGpPWpGaD
Sirolimus—CYP3A4—female reproductive system—uterine fibroid	0.00301	0.00436	CbGeAlD
Sirolimus—MTOR—DAP12 interactions—TNRC6B—uterine fibroid	0.00299	0.00967	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00299	0.00967	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00299	0.00967	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—TNRC6B—uterine fibroid	0.00296	0.00958	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00294	0.0095	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—TNRC6B—uterine fibroid	0.00292	0.00946	CbGpPWpGaD
Sirolimus—ABCB1—uterine cervix—uterine fibroid	0.00284	0.00412	CbGeAlD
Sirolimus—MTOR—B Cell Activation—TNRC6B—uterine fibroid	0.00277	0.00895	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—TNRC6B—uterine fibroid	0.00274	0.00888	CbGpPWpGaD
Sirolimus—ABCB1—decidua—uterine fibroid	0.00271	0.00392	CbGeAlD
Sirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00265	0.00856	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.00264	0.00855	CbGpPWpGaD
Sirolimus—ABCB1—urethra—uterine fibroid	0.00261	0.00378	CbGeAlD
Sirolimus—ABCB1—endometrium—uterine fibroid	0.00257	0.00372	CbGeAlD
Sirolimus—ABCB1—mammalian vulva—uterine fibroid	0.00249	0.0036	CbGeAlD
Sirolimus—CYP3A7—Biological oxidations—CYP17A1—uterine fibroid	0.00241	0.00781	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB4—ESR1—uterine fibroid	0.00241	0.00778	CbGpPWpGaD
Sirolimus—CYP3A7—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00238	0.0077	CbGpPWpGaD
Sirolimus—ABCB1—uterus—uterine fibroid	0.00237	0.00343	CbGeAlD
Sirolimus—FGF2—Disease—HPSE2—uterine fibroid	0.00235	0.0076	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—TNRC6B—uterine fibroid	0.00217	0.00702	CbGpPWpGaD
Sirolimus—ABCB1—female reproductive system—uterine fibroid	0.00213	0.00308	CbGeAlD
Sirolimus—FGF2—Developmental Biology—MED12—uterine fibroid	0.00212	0.00685	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—TNRC6B—uterine fibroid	0.00204	0.00659	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.002	0.00648	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—MED12—uterine fibroid	0.00195	0.0063	CbGpPWpGaD
Sirolimus—ABCB1—female gonad—uterine fibroid	0.00194	0.00281	CbGeAlD
Sirolimus—ABCB1—vagina—uterine fibroid	0.00193	0.00279	CbGeAlD
Sirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00188	0.00609	CbGpPWpGaD
Sirolimus—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.00186	0.00601	CbGpPWpGaD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.00179	0.0058	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—ESR1—uterine fibroid	0.00178	0.00577	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—CYP17A1—uterine fibroid	0.00175	0.00564	CbGpPWpGaD
Sirolimus—MTOR—Disease—HPSE2—uterine fibroid	0.00174	0.00564	CbGpPWpGaD
Sirolimus—CYP3A5—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00172	0.00557	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—TNRC6B—uterine fibroid	0.00164	0.0053	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—TNRC6B—uterine fibroid	0.00163	0.00527	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—PGR—uterine fibroid	0.00161	0.00522	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—TNRC6B—uterine fibroid	0.00157	0.00506	CbGpPWpGaD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00153	0.00494	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—TNRC6B—uterine fibroid	0.0015	0.00486	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—HPSE2—uterine fibroid	0.00126	0.00406	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.00121	0.0039	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—TNRC6B—uterine fibroid	0.00116	0.00376	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—HPSE2—uterine fibroid	0.00115	0.00373	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—TNRC6B—uterine fibroid	0.00112	0.00361	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TNRC6B—uterine fibroid	0.00111	0.00359	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TNRC6B—uterine fibroid	0.00106	0.00343	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—PGR—uterine fibroid	0.00105	0.0034	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.00101	0.00327	CbGpPWpGaD
Sirolimus—FGF2—Immune System—TNRC6B—uterine fibroid	0.000912	0.00295	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—ESR1—uterine fibroid	0.000862	0.00279	CbGpPWpGaD
Sirolimus—FGF2—Disease—TNRC6B—uterine fibroid	0.000842	0.00272	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—HPSE2—uterine fibroid	0.000833	0.00269	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.000811	0.00262	CbGpPWpGaD
Sirolimus—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.0008	0.00259	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TNRC6B—uterine fibroid	0.000778	0.00252	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—PGR—uterine fibroid	0.00077	0.00249	CbGpPWpGaD
Sirolimus—MTOR—Immune System—TNRC6B—uterine fibroid	0.000677	0.00219	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.00064	0.00207	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—HPSE2—uterine fibroid	0.000628	0.00203	CbGpPWpGaD
Sirolimus—MTOR—Disease—TNRC6B—uterine fibroid	0.000625	0.00202	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TNRC6B—uterine fibroid	0.000589	0.00191	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PGR—uterine fibroid	0.000583	0.00189	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—ESR1—uterine fibroid	0.00056	0.00181	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—MED12—uterine fibroid	0.000537	0.00174	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—MED12—uterine fibroid	0.000493	0.0016	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CYP17A1—uterine fibroid	0.00045	0.00146	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TNRC6B—uterine fibroid	0.000437	0.00141	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PGR—uterine fibroid	0.000433	0.0014	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CYP17A1—uterine fibroid	0.000413	0.00134	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—ESR1—uterine fibroid	0.000411	0.00133	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—HPSE2—uterine fibroid	0.000387	0.00125	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MED12—uterine fibroid	0.000357	0.00115	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—ESR1—uterine fibroid	0.000312	0.00101	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CYP17A1—uterine fibroid	0.000298	0.000965	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MED12—uterine fibroid	0.000269	0.00087	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ESR1—uterine fibroid	0.000231	0.000748	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CYP17A1—uterine fibroid	0.000225	0.000728	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MED12—uterine fibroid	0.000166	0.000536	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CYP17A1—uterine fibroid	0.000139	0.000449	CbGpPWpGaD
